Evaluation of the use of benzodiazepines in an elderly population in the interior of Bahia
DOI:
https://doi.org/10.25118/2763-9037.2023.v13.482Keywords:
benzodiazepines, prevalence, elderlyAbstract
Introduction: The elderly population is more vulnerable to the adverse effects of benzodiazepines due to higher risk of having multiple comorbidities, polypharmacy and drug interactions. Objective: To evaluate the prescription of benzodiazepines in the elderly population in a Health Center in the interior of Bahia. Methods: This is a descriptive, retrospective, observational and cross-sectional study, which included elderly patients over 60 years old. A selection of the patient population from the clinic was carried out, meeting the inclusion and exclusion criteria, an epidemiological survey through a only one structured interview and Mini Mental State Examination to assess their cognition. Data was analyzed using the Statistical Package for Social Sciences software (SPSS Inc., Chicago, IL, USA), version 14.0, and the variables were expressed in frequency and percentages and, for comparison between them, the Test of the Chi Square was utilized. Finally, p value≤0.05 was established to demonstrate statistical significance. Results: The rate of benzodiazepines use in this population was 65%, with a predominance of clonazepam (39.1%) and diazepam (29.7%). The specialists who most prescribed benzodiazepines were psychiatrists (53.9%) followed by practitioners (32%). Among the elderly who use benzodiazepines, 41.4% were instructed to make a discontinuation attempt, and of these, 35.8% managed to complete the request. Among those who tried and were unsuccessful, the main causes of failure were abrupt stop of the medication (44.1%) and recurrence of symptoms during gradual tapering off process (32.4%). Conclusions: The study demonstrated a high prevalence of benzodiazepine use in the elderly in this sample, with low incentive to discontinue these medications, tending to its abuse with aging. Therefore, strategies to discontinue benzodiazepines should be encouraged, as well as the training of the entire team in dealing with this public health issue.
Downloads
References
Nunes BS, Bastos FM. Efeitos colaterais atribuídos ao uso indevido e prolongado de benzodiazepínicos. Saude Cienc Ação. 2016;3(1):71-82. https://revistas.unifan.edu.br/index.php/RevistaICS/article/viewFile/234/177
Picton JD, Marino AB, Nealy KL. Benzodiazepine use and cognitive decline in the elderly. Am J Health Syst Pharm. 2018;75(1):e6-12. https://doi.org/10.2146/ajhp160381 - PMID:29273607
Martinelli AN. Rapid fire: polypharmacy in the geriatric patient. Emerg Med Clin North Am. 2021;39(2):395-404. https://doi.org/10.1016/j.emc.2021.01.001 - PMID:33863467
Robinson P. Pharmacology, polypharmacy and the older adult: a review. Br J Community Nurs. 2021;26(6):290-5. https://doi.org/10.12968/bjcn.2021.26.6.290 - PMID:34105364
Nastasy H, Ribeiro M, Marques ACPR. Abuso e dependência de benzodiazepínicos. Rio de Janeiro: Associação Brasileira de Psiquiatria; 2008. (Projeto Diretrizes). https://amb.org.br/files/_BibliotecaAntiga/abuso-e-dependencia-dos-benzodiazepinicos.pdf
Williams S, Miller G, Khoury R, Grossberg GT. Rational deprescribing in the elderly. Ann Clin Psychiatry. 2019;31(2):144-52. - PMID:31046036
Oliveira MG, Amorim WW, Oliveira CRB, Coqueiro HL, Gusmão LC, Passos LC. Consenso brasileiro de medicamentos potencialmente inapropriados para idosos. Geriatr Gerontol Aging. 2016;10(4):168-81. https://doi.org/10.5327/Z2447-211520161600054
Oliveira HSB, Manso MEG. Tríade iatrogênica em um grupo de mulheres idosas vinculadas a um plano de saúde. Rev Bras Geriatr Gerontol. 2019;22(1):e180188. https://doi.org/10.1590/1981-22562019022.180188
Duque AS, Gruner H, Clara JG, Ermida JG, Verissimo MT. Avaliação geriátrica. Lisboa: Núcleo de Estudos de Geriatria da Sociedade Portuguesa de Medicina Interna; 2012. p. 1-20. https://www.spmi.pt/wp-content/uploads/GERMI_36.pdf
Alvarenga JM, Loyola Filho AI, Firmo JOA, Lima-Costa MF, Uchoa E. A population based study on health conditions associated with the use of benzodiazepines among older adults (The Bambuí health and aging study). Cad Saude Publica. 2009;25(3):605-12. https://doi.org/10.1590/S0102-311X2009000300015 - PMID:19300849
Fiorelli K, Assini FL. A prescrição de benzodiazepínicos no Brasil: uma análise da literatura. Arq Bras Cienc Saude. 2017;42(1):40-4. https://doi.org/10.7322/abcshs.v42i1.948
Alvim MM, Cruz DT, Vieira MT, Bastos RR, Leite ICG. Prevalência e fatores associados ao uso de benzodiazepínicos em idosos da comunidade. Rev Bras Geriatr Gerontol. 2017;20(4):463-74. https://doi.org/10.1590/1981-22562017020.170042
Medeiros Filho JSA, Azevedo DM, Pinto TR, Silva GWS. Uso de psicofármacos na atenção primária à saúde. Rev Bras Promoç Saude. 2018;31(3):1-12. https://doi.org/10.5020/18061230.2018.7670
Mezzari R, Iser BPM. Desafios na prescrição de benzodiazepínicos em unidades básicas de saúde. Rev AMRIGS. 2015;59(3):198-203.
Pontes CAL, Silveira LC. Abuso de benzodiazepínicos entre mulheres: o que esse fenômeno (re)vela? Sanare (Sobral). 2017;16(1):15-23. https://sanare.emnuvens.com.br/sanare/article/view/1089/600
Prado MAMB, Francisco PMSB, Barros MBA. Uso de medicamentos psicotrópicos em adultos e idosos residentes em Campinas, São Paulo: um estudo transversal de base populacional. Epidemiol Serv Saude. 2017;26(4):747-58. https://doi.org/10.5123/S1679-49742017000400007 PMID:29211139
Naloto DCC, Lopes FC, Barberato Filho S, Lopes LC, Del Fiol FS, Bergamaschi CC. Prescrição de benzodiazepínicos para adultos e idosos de um ambulatório de saúde mental. Cien Saude Colet. 2016;21(4):1267-76. https://doi.org/10.1590/1413-81232015214.10292015 - PMID:27076025
Olfson M, King M, Schoenbaum M. Benzodiazepine use in the United States. JAMA Psychiatry. 2015;72(2):136-42. https://doi.org/10.1001/jamapsychiatry.2014.1763 - PMID:25517224
American Psychiatric Association. Manual de diagnóstico e estatística de distúrbios mentais: DSM-5. 5. ed. Porto Alegre: Artmed; 2014. http://www.institutopebioetica.com.br/documentos/manual-diagnostico-e-estatistico-de-transtornos-mentais-dsm-5.pdf
Santos HS, Nestor AGS. A utilização dos medicamentos psicotrópicos e seus fatores associados. Rev Iniciaç Cient Extensão. 2018;1(1):51-6. https://revistasfacesa.senaaires.com.br/index.php/iniciacao-cientifica/article/view/48
Senicato C, Lima MG, Barros MBA. Ser trabalhadora remunerada ou dona de casa associa-se à qualidade de vida relacionada à saúde? Cad Saude Publica. 2016;32(8):e00085415. https://doi.org/10.1590/0102-311X00085415 - PMID:27509549
Mattos M, Curcio LA, Souza JKR, Alarcon PP, Santos DAS, Goulart LS, Castro LS. Perfil de consumo de benzodiazepínicos e condições de saúde dos usuários na estratégia saúde da família. Rev AMRIGS. 2021;65(4):1-5. https://docs.bvsalud.org/biblioref/2022/09/1391944/ao-2951.pdf
Campanha AM. Utilização de psicofármacos pela população geral residente na região metropolitana de São Paulo [tese]. [São Paulo]: Universidade de São Paulo; 2015. https://teses.usp.br/teses/disponiveis/5/5142/tde-09062015-153011/publico/AngelaMariaCampanhaVersaoCorrigida.pdf
Fegadollii C, Varela NMD, Carlini ELA. Uso e abuso de benzodiazepínicos na atenção primária à saúde: práticas profissionais no Brasil e em Cuba. Cad Saude Publica. 2019;35(6):e00097718. https://doi.org/10.1590/0102-311x00097718 - PMID:31291423
Mendes KCC. O uso prolongado de benzodiazepínicos - uma revisão de literatura [monografia]. [Pompéu]: Universidade Federal de Minas Gerais; 2013.
Azevedo AJP, Araújo AA, Ferreira MAF. Consumo de ansiolíticos benzodiazepínicos: uma correlação entre dados do SNGPC e indicadores sociodemográficos nas capitais brasileiras. Cienc Saude Colet. 2016;21(1):83-90. https://doi.org/10.1590/1413-81232015211.15532014 PMID:26816166
Downloads
Published
How to Cite
Conference Proceedings Volume
Section
License
Copyright (c) 2023 Jefferson Meira Pires
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria allows the author (s) to keep their copyrights unrestricted. Allows the author (s) to retain their publication rights without restriction. Authors should ensure that the article is an original work without fabrication, fraud or plagiarism; does not infringe any copyright or right of ownership of any third party. Authors should also ensure that each one complies with the authorship requirements as recommended by the ICMJE and understand that if the article or part of it is flawed or fraudulent, each author shares responsibility.
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) - Debates em Psiquiatria is governed by the licencse CC-By-NC
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
